Back to Capital Research Global Investors Capital Research Global Investors

SRPTSRPT
13 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in SAREPTA THERAPEUTICS INC

No. Capital Research Global Investors exited its SRPT (Sarepta Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 557,461 shares worth $67.6M. Capital Research Global Investors first reported SRPT in Q4 2019 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$310.9M

Total Shares Change

-2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$96.43
0
2023-Q3
Increased
557,461
+0.0%
$67.6M0.0%$121.22
29
2023-Q2
Increased
557,383
+109.6%
$63.8M0.0%$114.52
48
2023-Q1
New
265,941
-
$36.7M0.0%$137.83
40
2021-Q4
Exited
0
-100.0%
$00.0%$90.05
0
2021-Q3
Decreased
2.5M
-46.5%
$235.1M0.1%$92.48
0
2021-Q2
Decreased
4.8M
-40.8%
$369.3M0.1%$77.74
0
2021-Q1
Increased
8M
+3.8%
$598.2M0.1%$74.53
39
2020-Q4
Increased
7.7M
+15.3%
$1.3B0.3%$170.49
44
2020-Q3
Increased
6.7M
+42.6%
$942.5M0.3%$140.43
51
2020-Q2
Increased
4.7M
+21.4%
$754.3M0.2%$160.34
45
2020-Q1
Increased
3.9M
+60.9%
$379M0.1%$97.82
54
2019-Q4
New
2.4M
-
$310.9M0.1%$129.04
43

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used